Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group

Central South University

Status: Unknown

Conditions: Schizophrenia

Study type: Observational

Funder types: Other

Identifiers

NCT03965598

81871056

Details and patient eligibility

About

Considering the complex pathological mechanism and the poor treatment outcomes of schizophrenia, early detection and intervention gradually become the key work for the foundational and clinical research in schizophrenia. Ultra-high risk for psychosis (UHP) is defined as individuals at the prodromal stage of schizophrenia. Early intervention in individual at UHP can effectively delay or even prevent the development of the illness. Long-term longitudinal studies suggested that there are clinical outcomes in people at UHP. Nearly 1/3 of individuals at UHP may be naturally relieved without any intervention, about 1/3 of individuals at UHP will remain at the prodromal stage of schizophrenia, and only 1/3 individuals at UHP will eventually develop schizophrenia. In this regard, it will cause adverse effects on false positive individuals if they accept clinical intervention. Unfortunately, it is difficult to accurately predict which individuals at UHP will make a transition to frank illness. To solve this issue, we explore the association between baseline brain structural and functional networks, methylation modifications, gene expression, neurocognitive function and the clinical outcomes of UHP individuals, and to identify the potential biological and clinical predictors for the long-term outcomes in the individuals at UHP. In addition, we also detect the changes of brain structure and function, methylation status and gene expression in individuals at UHP during follow-up, and further to investigate the etiology and pathogenesis of schizophrenia.

Enrollment: 200 estimated patients

Sex: All

Ages: 13 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 1. age of 13-30 years;
• 2. meet the diagnostic criteria of COPS prodromal syndrome by SIPS clinical interviews;
• 3. have not received any psychiatric medication;
• 4. be in good health, without major mental illness or physical illness;
• 5. normal intelligence, can be operated on a clinical scale;
• 6. volunteer to participate in the study and sign the written consent form.

Exclusion criteria

• 1. exclusion of current or previous psychiatric disorders by SCID interview;
• 2. meet the diagnostic criteria for substance abuse and substance dependence in DSM-IV;
• 3. contraindications for MRI;
• 4. pregnant or lactating women.

Trial design

200 participants in 2 patient groups

Ultra-high risk for psychosis (UHP)

Description:

Ultra-high risk for psychosis (UHP) is defined as individuals at the prodromal stage of schizophrenia. Inclusion Criteria: age of 13-30 years; meet the diagnostic criteria of COPS prodromal syndrome by SIPS clinical interviews; have not received any psychiatric medication; be in good health, without major mental illness or physical illness; normal intelligence, can be operated on a clinical scale; volunteer to participate in the study and sign the written consent form. Exclusion criteria: exclusion of current or previous psychiatric disorders by SCID interview; meet the diagnostic criteria for substance abuse and substance dependence in DSM-IV; contraindications for MRI; pregnant or lactating women.

Healthy controls

Description:

Inclusion Criteria: the gender, age, and education level of the group are matched with the Ultra-high risk group; 13 to 30 years old; right-handed; no history of mental illness; no mental disorder consistent with DSM-IV diagnostic criteria within two or three generations; No contraindications for MRI; volunteer to participate in the study and sign the written consent form. Exclusion criteria: history of disturbance of consciousness over 5 minutes; history of brain organic disease or head injury; history of alcohol and drug dependence; history of coma; history of endocrine disease; abnormity in examination of blood, heart, liver, or renal function; pregnant or lactating women.